Literature DB >> 32371553

Reasons for Not Attending Cervical Cancer Screening and Associated Factors in Rural Ethiopia.

Muluken Gizaw1,2, Brhanu Teka3, Friederike Ruddies2, Konjit Kassahun4, Dawit Worku5, Alemayehu Worku1, Andreas Wienke2, Rafael Mikolajczyk2, Ahmedin Jemal6, Andreas M Kaufmann7, Tamrat Abebe3, Adamu Addissie1,2, Eva Johanna Kantelhardt8,9.   

Abstract

Social, economic, and cultural factors have been associated with the level of participation in cervical cancer screening programs. This study identified factors associated with nonparticipation in cervical cancer screening, as well as reasons for not attending, in the context of a population-based, cluster-randomized trial in Ethiopia. A total of 2,356 women aged 30 to 49 years in 22 clusters were invited to receive one of two screening approaches, namely human papillomavirus (HPV) self-sampling or visual inspection with acetic acid (VIA). Participants and nonparticipants were analyzed according to their sociodemographic and economic characteristics. Reasons were determined for the refusal of women to participate in either screening method. More women in the VIA arm compared to the HPV arm declined participation in the screening [adjusted OR (AOR) 3.5; 95% confidence interval (CI), 2.6-4.8]. Women who declined attending screening were more often living in rural areas (AOR = 2.0; 95% CI, 1.1-3.5) and were engaged in informal occupations (AOR = 1.6; 95% CI, 1.1-2.4). The majority of nonattendants perceived themselves to be at no risk of cervical cancer (83.1%). The main reasons given for not attending screening for both screening approaches were lack of time to attend screening, self-assertion of being healthy, and fear of screening. We found that perceived time constraints and the perception of being at no risk of getting the disease were the most important barriers to screening. Living in rural settings and informal occupation were also associated with lower participation. Offering a swift and convenient screening service could increase the participation of women in cervical cancer screening at the community level. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32371553     DOI: 10.1158/1940-6207.CAPR-19-0485

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  7 in total

1.  Women's sexual autonomy as a determinant of cervical cancer screening uptake in Addis Ababa, Ethiopia: a case-control study.

Authors:  Miresa Midaksa; Alemnew Destaw; Adamu Addissie; Eva Johanna Kantelhardt; Muluken Gizaw
Journal:  BMC Womens Health       Date:  2022-06-17       Impact factor: 2.742

2.  Challenges in the Prevention of Cervical Cancer in Romania.

Authors:  Raluca Dania Todor; Gabriel Bratucu; Marius Alexandru Moga; Adina Nicoleta Candrea; Luigi Geo Marceanu; Costin Vlad Anastasiu
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

3.  Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community-based cross-sectional study.

Authors:  Shewaye F Natae; Digafe T Nigatu; Mulu K Negawo; Wakeshe W Mengesha
Journal:  Cancer Med       Date:  2021-10-27       Impact factor: 4.452

4.  A Technical Comparison of Human Papillomavirus Genotyping Assays from a Population-Based Cervical Cancer Screening in South Central Ethiopia.

Authors:  Brhanu Teka; Muluken Gizaw; Ededia Firdawoke; Adamu Addissie; Tesfamichael Awoke Sisay; Carola Schreckenberger; Anna Sophie Skof; Sarah Thies; Adane Mihret; Eva Johanna Kantelhardt; Tamrat Abebe; Andreas M Kaufmann
Journal:  Cancer Manag Res       Date:  2022-07-29       Impact factor: 3.602

5.  Towards a cervical cancer-free future: women's healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa.

Authors:  Joshua Okyere; Richard Gyan Aboagye; Abdul-Aziz Seidu; Bernard Yeboah-Asiamah Asare; Bupe Mwamba; Bright Opoku Ahinkorah
Journal:  BMJ Open       Date:  2022-07-29       Impact factor: 3.006

6.  Factors associated with cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania: A cross-sectional study.

Authors:  Meshack R Mwantake; Happiness D Kajoka; Faustini C Kimondo; Caroline Amour; Innocent B Mboya
Journal:  Prev Med Rep       Date:  2022-09-19

7.  Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.

Authors:  Joshua Okyere; Precious Adade Duodu; Livingstone Aduse-Poku; Pascal Agbadi; Jerry John Nutor
Journal:  BMC Public Health       Date:  2021-06-05       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.